A new FDA approval stands to give Daiichi Sankyo’s Turalio some company in a rare tumor type. | The new FDA approval gives ...

The FDA has approved Evrysdi in tablet form for patients with spinal muscular atrophy aged 2 years and older who weigh more ...

The U.S. Food and Drug Administration (FDA) has approved a new tablet formulation of Evrysdi (risdiplam), an approved oral ...

In the face of tough competition from Apellis and a recent setback with prescribers, Astellas’ geographic atrophy (GA) med ...

Looking for more exciting features on the latest technology? Check out our What We Know So Far section or our Fun Reads for some interesting original features.

The right drawing tablet can make all the difference in bringing your creative vision to life. It should feel like an extension of your hand, translating every brushstroke with precision and fluidity.

Most of the tablets included in this guide are older-generation models, so you may have to visit third-party retailers to pick them up, but where possible, we've provided links to those retailers ...

Rybelsus (semaglutide) is a brand-name oral tablet prescribed for type 2 diabetes ... digestive side effects were more common in people taking a 14-mg dose than in those taking a 7-mg dose.

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ingredient, they are approved for different purposes. Ozempic is primarily ...

Today, only Rybelsus is available as an oral ... depending on the dosage. Adults with diabetes lost 12.8% to 14.7% of their body weight. In comparison, placebo groups saw weight reductions of ...

Rybelsus (semaglutide) is a brand-name prescription medication that doctors prescribe alongside exercise and diet to help improve blood sugar levels in adults with type 2 diabetes. Plans often ...